Atom Investors’s LeMaitre Vascular LMAT Stock Holding History

Atom Investors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-30,456	Closed	-$720K	–	627
2018 Q4	$720K	Buy	+30,456	New	+$832K	0.07%	388

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Atom Investors's LMAT Position: Q1 2019 in Review

Atom Investors sold out of LeMaitre Vascular (LMAT) in Q1 2019, closing a stake of 30,456 shares — an estimated $720K sold.

Atom Investors first reported a position in LMAT in Q4 2018 and held it in 1 quarter. The position peaked at $720K in Q4 2018. 155 funds tracked by Wall St. Rank hold LMAT as of Q1 2019.

Atom Investors reported no remaining LeMaitre Vascular position as of Q1 2019 after selling out during the quarter.
Atom Investors sold 30,456 LeMaitre Vascular shares in Q1 2019, an estimated $720K.
Atom Investors first reported a position in LeMaitre Vascular in Q4 2018 and held it in 1 quarter.
Atom Investors's LeMaitre Vascular position peaked at $720K in Q4 2018.
155 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2019.

Based on Atom Investors's 13F filing for Q1 2019, filed 15 May 2019.